Skip to main content
Log in

A prospective study of serum ghrelin levels in patients treated with clozapine

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

We investigated serum ghrelin levels (SGL) in 12 patients with schizophrenia over a 10-week period after initiation of clozapine treatment. In contrast to increments of body mass indices (BMI, kg/m2) and serum leptin levels (SLL), no significant change in SGL was detected. Inverse correlations between delta SGL and delta SLL did not reach statistical significance. Linear mixed model analysis could not detect effects of age, sex, BMI, SLL and serum clozapine levels on SGL. Our results do not support a causal involvement of ghrelin in clozapine-related weight gain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • DB Allison JL Mentore M Heo LP Chandler JC Cappelleri MC Infante PJ Weiden (1999) ArticleTitleAntipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156 1686–1696 Occurrence Handle10553730

    PubMed  Google Scholar 

  • M Atmaca M Kuloglu E Tezcan B Ustundag (2003) ArticleTitleSerum leptin and triglyceride levels in patients on treatment with atypical antipsychotics. J Clin Psychiatry 64 598–604 Occurrence Handle12755665

    PubMed  Google Scholar 

  • T Baptista A Lacruz S de Mendoza JM Mendoza Guillen R Silvera F Angeles MT Mendoza L Hernandez (2000) ArticleTitleBody weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry 33 81–88 Occurrence Handle10.1055/s-2000-8451 Occurrence Handle10855458

    Article  PubMed  Google Scholar 

  • T Brömel WF Blum A Ziegler E Schulz M Bender C Fleischhaker H Remschmidt JC Krieg J Hebebrand (1998) ArticleTitleSerum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 3 76–80 Occurrence Handle10.1038/sj.mp.4000352 Occurrence Handle9491817

    Article  PubMed  Google Scholar 

  • Brown H, Prescott R (1999) Applied mixed models in medicine. John Wiley & Sons, Chichester New York Weinheim Brisbane Singapore Toronto

  • JM Friedman JL Halaas (1998) ArticleTitleLeptin and the regulation of body weight in mammals. Nature 395 763–770 Occurrence Handle10.1038/27376 Occurrence Handle9796811

    Article  PubMed  Google Scholar 

  • D Gothelf B Falk P Singer M Kairi M Phillip L Zigel I Poraz S Frishman N Constantini G Zalsman A Weizman A Apter (2002) ArticleTitleWeight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 159 1055–1057 Occurrence Handle10.1176/appi.ajp.159.6.1055 Occurrence Handle12042200

    Article  PubMed  Google Scholar 

  • T Kraus M Haack A Schuld D Hinze-Selch M Kuhn M Uhr T Pollmächer (1999) ArticleTitleBody weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156 312–314 Occurrence Handle9989571

    PubMed  Google Scholar 

  • R Leadbetter M Shutty D Pavalonis V Vieweg P Higgins M Downs (1992) ArticleTitleClozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 149 68–72 Occurrence Handle1728188

    PubMed  Google Scholar 

  • M Nakazato N Murakami Y Date M Kojima H Matsuo K Kangawa S Matsukura (2001) ArticleTitleA role for ghrelin in the central regulation of feeding. Nature 409 194–198 Occurrence Handle10.1038/35051587 Occurrence Handle11196643

    Article  PubMed  Google Scholar 

  • B Otto U Cuntz E Fruehauf R Wawarta C Folwaczny RL Riepl ML Heiman P Lehnert M Fichter M Tschöp (2001) ArticleTitleWeight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145 669–673 Occurrence Handle10.1530/eje.0.1450669

    Article  Google Scholar 

  • E Schulz C Fleischhaker H Remschmidt (1995) ArticleTitleDetermination of clozapine and its major metabolites in serum samples of adolescent schizophrenic patients by high-performance liquid chromatography – data from a prospective clinical trial. Pharmacopsychiatry 28 20–25 Occurrence Handle7746841

    PubMed  Google Scholar 

  • FM Theisen S Cichon A Linden M Martin H Remschmidt J Hebebrand (2001) ArticleTitleClozapine and weight gain. Am J Psychiatry 158 816 Occurrence Handle10.1176/appi.ajp.158.5.816

    Article  Google Scholar 

  • FM Theisen A Linden IR König M Martin H Remschmidt J Hebebrand (2003) ArticleTitleSpectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 110 111–121 Occurrence Handle12541016

    PubMed  Google Scholar 

  • T Togo K Hasegawa S Miura H Hosojima K Kojima M Shoji A Kase H Uchikado E Iseki K Kosaka (2004) ArticleTitleSerum ghrelin concentrations in patients receiving olanzapine or risperidone. Psychopharmacology 172 230–232 Occurrence Handle10.1007/s00213-003-1642-4 Occurrence Handle14551671

    Article  PubMed  Google Scholar 

  • M Tschöp DL Smiley ML Heiman (2000) ArticleTitleGhrelin induces adiposity in rodents. Nature 407 908–913

    Google Scholar 

  • M Tschöp C Weyer AP Tataranni V Devanarayan E Ravussin ML Heiman (2001) ArticleTitleCirculating ghrelin levels are decreased in human obesity. Diabetes 50 707–709 Occurrence Handle11289032

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Theisen, F., Gebhardt, S., Brömel, T. et al. A prospective study of serum ghrelin levels in patients treated with clozapine. J Neural Transm 112, 1411–1416 (2005). https://doi.org/10.1007/s00702-005-0284-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-005-0284-6

Navigation